landmark NIH hypertension study will shake things up

January 2003

The surprising results from the landmark NIH hypertension study will shake things up.

The "modern" ACE inhibitors, calcium channel blockers, and beta-blockers won't be first choice for most patients anymore.

The huge ALLHAT study shows that a good old diuretic is often better.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote